To hear about similar clinical trials, please enter your email below
Trial Title:
Cross-sectional Study of Chinese Liver Cancer Patients
NCT ID:
NCT05872828
Condition:
Liver Cancer
Conditions: Official terms:
Liver Neoplasms
Study type:
Observational [Patient Registry]
Overall status:
Enrolling by invitation
Study design:
Time perspective:
Cross-Sectional
Intervention:
Intervention type:
Other
Intervention name:
No intervention
Description:
Observational study. No intervention will be adopted.
Summary:
The goal of this cross-sectional study is to investigate the prevalence and risk factors
of anxiety and depression and their relationships with immune functions and quality of
life among liver cancer patients in the COVID-19 pandemic era. The objectives of this
study are:
1. To examine the prevalence of anxiety and depression among patients with liver cancer
during the COVID-19 pandemic.
2. To identify risk factors associated with anxiety and depression among these
patients.
3. To determine the association between anxiety, depression, immune function, and
quality of life among liver cancer patients.
Participants will be asked to fill a digital questionnaire.
Criteria for eligibility:
Study pop:
Adults patients of liver cancer.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion criteria
Participants must meet all the following criteria for study entry:
1. Aged 18 or older.
2. Participants have a confirmed diagnosis of liver cancer in the medical records.
3. Participants are able to communicate with Chinese. Exclusion criteria
Participants who meet any of the following criteria will be excluded from study entry:
1. Participant has multiple organ failure which makes him/her incapable to comply with
the study protocol.
2. Participant has hepatic encephalopathy or severe mental disorder which makes him/her
incapable of understanding the meanings of the questionnaires.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Zhuhai People's Hospital
Address:
City:
Zhuhai
Zip:
519000
Country:
China
Start date:
April 1, 2023
Completion date:
April 30, 2024
Lead sponsor:
Agency:
The Nethersole School of Nursing
Agency class:
Other
Source:
The Nethersole School of Nursing
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05872828
http://qol.eortc.org/.
